TELA Bio TELA

$ 2.93 1.03%

Quarterly report 2024-Q3
added 11-08-2024

TELA Bio Balance Sheet 2011-2024 | TELA

Annual Balance Sheet TELA Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-5.65 M	-1.76 M	-12.4 M	-43.6 M	-5.77 M	12.5 M	-6.83 M	-	-	-	-	-	-
Long Term Debt	40.5 M	39.9 M	31.5 M	30.8 M	30.2 M	29.7 M	3.61 M	-	-	-	-	-	-
Long Term Debt Current	565 K	340 K	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	30.2 M	156 M	118 M	-	-	-	-	-	-
Total Current Liabilities	17 M	12.4 M	10.6 M	6.6 M	6.71 M	-	-	-	-	-	-	-	-
Total Liabilities	59.2 M	53.6 M	42.4 M	37.4 M	37 M	165 M	124 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-321 M	-274 M	-230 M	-197 M	-168 M	-138 M	-108 M	-	-	-	-	-	-
Total Assets	78 M	67.9 M	62.5 M	86.5 M	67.9 M	27.2 M	15.5 M	-	-	-	-	-	-
Cash and Cash Equivalents	46.7 M	42 M	43.9 M	74.4 M	45.3 M	17.3 M	11.3 M	-	-	-	-	-	-
Book Value	18.9 M	14.3 M	20.1 M	49 M	31 M	-138 M	-108 M	-	-	-	-	-	-
Total Shareholders Equity	18.9 M	14.3 M	20.1 M	49 M	31 M	-138 M	-108 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet TELA Bio

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	41 M	40.8 M	40.5 M	40.4 M	40.2 M	40.1 M	39.9 M	39.8 M	39.6 M	31.7 M	31.5 M	31.3 M	31.1 M	31 M	30.8 M	30.8 M	30.8 M	30.8 M	30.2 M	30.2 M	30.2 M	30.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	59.3 M	57.3 M	59.2 M	56.8 M	54.4 M	55.6 M	53.6 M	56.3 M	52.9 M	45.3 M	42.4 M	41.1 M	38.8 M	36.6 M	37.4 M	37.4 M	37.4 M	37.4 M	37 M	37 M	37 M	37 M	40.9 M	40.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-350 M	-339 M	-321 M	-308 M	-297 M	-286 M	-274 M	-264 M	-254 M	-241 M	-230 M	-221 M	-213 M	-205 M	-197 M	-197 M	-197 M	-197 M	-168 M	-168 M	-168 M	-168 M	-138 M	-138 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	53 M	60.2 M	78 M	87.3 M	94.4 M	58.8 M	67.9 M	79.6 M	51.3 M	55.4 M	62.5 M	68.8 M	73.8 M	78.3 M	86.5 M	86.5 M	86.5 M	86.5 M	67.9 M	67.9 M	67.9 M	67.9 M	27.2 M	27.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	17.3 M	26.5 M	46.7 M	58.2 M	65.3 M	30.1 M	42 M	54.2 M	27.7 M	33 M	43.9 M	53.6 M	60.3 M	65.8 M	74.4 M	74.4 M	74.4 M	74.4 M	45.3 M	45.3 M	45.3 M	45.3 M	17.3 M	17.3 M	-	-	11.3 M	-	-	-	1.48 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-6.27 M	2.87 M	18.9 M	30.6 M	40 M	3.14 M	14.3 M	23.3 M	-1.54 M	10 M	20.1 M	27.7 M	35 M	41.7 M	49 M	49 M	49 M	49 M	31 M	31 M	31 M	31 M	-13.7 M	-13.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-6.27 M	2.87 M	18.9 M	30.6 M	40 M	3.14 M	14.3 M	23.3 M	-1.54 M	10 M	20.1 M	27.7 M	35 M	41.7 M	49 M	49 M	49 M	49 M	31 M	31 M	31 M	31 M	-138 M	-138 M	-124 M	-	-108 M	-	-	-	-81.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency